J-REIT Data

8972 Kenedix Office Investment Corporation

ケネディクス不動産投資法人が第7期決算を発表、資産運用会社に伊藤忠商事が資本参加

(Dec. 11, 2008)

ケネディクス不動産投資法人(KRI)が第7期(平成20年10月期)決算を発表した。第7期は3棟取得及び2棟売却を行った。賃貸収益が増加する一方、物件売却益が減少したため、前期比6.5%減益、1口当たり分配金は15,618円となった。第8期(平成21年4月期)は、前期の物件売却益がなくなること及び支払利息の増加等により7.8%減益、1口当たり分配金は14,400円となる見通し。KRIは現在の市場環境を鑑みて、当面資産規模の拡大は目標とせず、オフィスビルについては資産の入替、商業施設やレジデンスは売却を進めていく方向。また併せて、資産運用会社に伊藤忠商事が参画することを発表。現在ケネディクスが保有する資産運用会社の全株式のうち10%を伊藤忠商事に売却する。

  第7期実績 第8期予想 前期比
営業収益 8,456百万円 8,298百万円 ▲1.9%
当期利益 3,123百万円 2,880百万円 ▲7.8%
分配金
(/1口)
15,618円 14,400円 ▲7.8%

Recent 5 news of Kenedix Office Investment Corporation
Nov. 6, 2014
Kenedix Office Investment Corporation : Issuance of New Investment Units and Secondary Offering of Investment Units, Acquisition of 5 Properties
Oct. 15, 2014
Kenedix Office Investment Corporation : Acquisition of "Urban Square Yokohama"
Sep. 30, 2014
Kenedix Office Investment Corporation to Acquire " Senri Life Science Center Building"
Aug. 25, 2014
Kenedix Office Investment Corporation to Acquire 2 Office Buildings.
Jul. 8, 2014
Kenedix Office Investment Corporation Sells KDX Minami Semba Dai-1 Building / Nissou Dai-17 Building, and announced the refund of Preferred Securities.

ReitInfo.com

Property Acquisition Price Rankings

(Billions of yen)

1 Roppongi Hills Mori Tower 115
2 Tokyo Shiodome Building 110
3 Shiodome Building 107
4 Kitanomaru Square 82
5 Garden City Shinagawa Gotenyama 72
Unit Price Growth Rankings
1 Nippon Healthcare +7.83%
2 Japan Rental Housing +6.02%
3 ONE REIT +5.43%
* This website provides information and data on J-REITs and is not intended as a solicitation for investment.
* The information appearing on this website has been carefully vetted, but the accuracy of the content is in no way guaranteed and may change without notice (that is, it may be modified or deleted).
* Users shall be responsible for the use of the information published on this website. The Company cannot be held liable whatsoever regarding the use of this information.
* Copyrights related to the information published on this website belong to the Company. The unauthorized use (diversion or reproduction, etc.) of this information is strictly prohibited.